Clinical Trial Update: Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing bevacizumab in combination with chemoimmunotherapy and atezolizumab for extensive-stage small-cell lung cancer with liver metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Liver Metastases

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Kamya Sankar | Conditions: Extensive-stage Small-cell Lung Cancer, Liver Metastases | Phase 2 | Status: RECRUITING